The latest twist in a particularly bitter takeover feud that has captivated the pharmaceutical industry and Wall Street now turns on allegations of insider trading Allergan filed a lawsuit claiming that Valeant Pharmaceuticals William Ackman and his Pershing Square Capital Management violated securities laws that prohibit insider trading and failed to disclose legally required information among other things Valeant and Mr Ackman teamed up in April to buy Allergan which is best known for selling Botox